Navigating FDA’s Complex Regulation of Homeopathic and Ayurvedic Products
The U.S. Food and Drug Administration (FDA) has announced its new medical device user fees for fiscal year 2025, effective October 1, 2024, highlighting significant
The FDA and FTC recently issued warning letters to several companies involved in the sale of Delta-8 THC products in packaging mimicking popular national brands
As we fire up the grills and get ready for fireworks this Independence Day, FDA is working to ensure that our food safety regulations are
Top 5 Violations in the Latest FDA Foreign Supplier Verification Warning Letters
